ST-elevation Myocardial Infarction: Clinical Trials

4 trials for ST-elevation Myocardial Infarction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 unknown. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Completed 3, Unknown 1

Follow ST-elevation Myocardial Infarction: new trials by email Literature Review of ST-elevation Myocardial Infarction trials Research Report on ST-elevation Myocardial Infarction

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Early Mineralocorticoid Receptor Antagonist Treatment to Reduce Myocardial Infarct Size
Mineralocorticoid receptor antagonist potassium-canrenoate, placebo - ST-elevation Myocardial Infarction
Phase 3CompletedUniversity College, London612013-11-012016-10-26
PraSugrel vs TicagrElor in ST-Elevation Myocardial Infarction paTients With Diabetes Mellitus
ticagrelor, prasugrel - ST-Elevation Myocardial Infarction
Phase 3CompletedGennaro Sardella502013-05-012017-06-28
The Clinical Effect of Intensive Statin Therapy in STEMI Patients Before Emergency PCI
Atorvastatin - ST-elevation Myocardial Infarction, (STEMI)
Phase 3UnknownGeneral Hospital of Chinese Armed Police Forces1502011-02-012011-04-13
Abciximab i.v. Versus i.c. in ST-elevation Myocardial Infarction
abciximab intracoronary, abciximab intravenously - ST-elevation Myocardial Infarction
Phase 3CompletedUniversity of Leipzig19122008-07-012011-04-20

Narrower conditions

ST Elevation Myocardial Infarction (4)  ·  Diabetes Mellitus (1)  ·  Infarction (1)  ·  Insulin Resistance (1)  ·  Reperfusion Injury (1)

Broader conditions

Cardiovascular Diseases (4)  ·  Heart Diseases (4)  ·  Ischemia (4)  ·  Myocardial Infarction (4)  ·  Myocardial Ischemia (4)  ·  Necrosis (4)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Vascular Diseases (4)  ·  Infarction (3)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Hyperinsulinism (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Atorvastatin (1)  ·  Prasugrel Hydrochloride (1)  ·  Ticagrelor (1)

Sponsors

General Hospital of Chinese Armed Police Forces (1)  ·  Gennaro Sardella (1)  ·  University College, London (1)  ·  University of Leipzig (1)

Countries

China (1)  ·  Germany (1)  ·  Italy (1)  ·  United Kingdom (1)

Top investigators

Anthony Mathur, PhD (1)  ·  Derek J Hausenloy, PhD (1)  ·  Gerhard Schuler, MD, PhD (1)  ·  Holger Thiele, MD, PhD (1)  ·  HuiLiang Liu, Doctor (1)  ·  Jochen Woehrle, MD, PhD (1)  ·  John Greenwood, MD (1)  ·  Pascal Meier, MD (1)  ·  Reto Gamma, MD (1)

Results publications

PMID 15007111, PMID 15861319, PMID 16168297, PMID 16337036, PMID 16916504, PMID 20362711, PMID 22015616, PMID 22357109, PMID 23410871, PMID 23466078, PMID 23973868, PMID 24994545, PMID 25049315, PMID 25236513, PMID 26060202, PMID 26174798, PMID 26235929, PMID 26481162, PMID 26691729, PMID 27832796, PMID 28474817, PMID 29122844, PMID 29391346, PMID 31278521, PMID 31329854, PMID 32335515, PMID 32873121, PMID 33083869, PMID 34767896, PMID 35851282, PMID 36268539, PMID 37046343